While Amneal Pharmaceuticals Inc has overperformed by 2.03%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, AMRX rose by 20.58%, with highs and lows ranging from $9.79 to $6.68, whereas the simple moving average jumped by 17.48% in the last 200 days.
On June 06, 2025, Goldman started tracking Amneal Pharmaceuticals Inc (NASDAQ: AMRX) recommending Buy. A report published by JP Morgan on February 24, 2025, Upgraded its rating to ‘Overweight’ for AMRX. JP Morgan also Upgraded AMRX shares as ‘Neutral’, setting a target price of $9 on the company’s shares in a report dated September 06, 2024. RBC Capital Mkts Initiated an Sector Perform rating on April 07, 2021, and assigned a price target of $5. Goldman March 08, 2021d its ‘Sell’ rating to ‘Buy’ for AMRX, as published in its report on March 08, 2021. Guggenheim’s report from December 14, 2020 suggests a price prediction of $5.50 for AMRX shares, giving the stock a ‘Buy’ rating. Barclays also rated the stock as ‘Overweight’.
Analysis of Amneal Pharmaceuticals Inc (AMRX)
Further, the quarter-over-quarter increase in sales is 3.24%, showing a positive trend in the upcoming months.
To gain a thorough understanding of Amneal Pharmaceuticals Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -155.38% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 0.88, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and AMRX is recording an average volume of 1.60M. On a monthly basis, the volatility of the stock is set at 3.07%, whereas on a weekly basis, it is put at 2.68%, with a gain of 0.21% over the past seven days. Furthermore, long-term investors anticipate a median target price of $12.00, showing growth from the present price of $9.55, which can serve as yet another indication of whether AMRX is worth investing in or should be passed over.
How Do You Analyze Amneal Pharmaceuticals Inc Shares?
A leading company in the Drug Manufacturers – Specialty & Generic sector, Amneal Pharmaceuticals Inc (AMRX) is based in the USA. When comparing Amneal Pharmaceuticals Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 1492.19, there is a growth in quarterly earnings of 269.68%.
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 53.89%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 41.92% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
